Last reviewed · How we verify

Senna alone

Camlıca Erdem Hospital · FDA-approved active Small molecule

Senna stimulates colonic muscle contractions and increases intestinal fluid secretion to promote bowel movements.

Senna stimulates colonic muscle contractions and increases intestinal fluid secretion to promote bowel movements. Used for Constipation, Bowel preparation before diagnostic procedures.

At a glance

Generic nameSenna alone
Also known asX-M solution (300 mg sennoside A+B calcium, Yenisehir Pharmaceuticals)
SponsorCamlıca Erdem Hospital
Drug classStimulant laxative
TargetColonic smooth muscle and intestinal epithelium
ModalitySmall molecule
Therapeutic areaGastroenterology
PhaseFDA-approved

Mechanism of action

Senna contains anthraquinone glycosides (sennosides) that are metabolized by colonic bacteria into active aglycones. These compounds irritate the colonic mucosa and stimulate peristalsis while also increasing water and electrolyte secretion into the intestinal lumen, resulting in a laxative effect that typically occurs 6-12 hours after ingestion.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: